Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 941-303-6 | CAS number: 1689576-55-3
Endpoint summary
Administrative data
Description of key information
Additional information
The bioconcentration factor of ‘Esterification products of 1,3-dioxo-2-benzofuran-5-carboxylic acid with nonan-1-ol’, calculated using the software tool T.E.S.T. v4.2.1 and applying the Consensus method, is in the following range: BCF= 4.54 ÷ 8.22
The key value is within the estimation range of the predicted BCFs of the 15 principal components of the assessed UVCB substance, showing that the potential for bioaccumulation is low.
This is supported by experimental data from a structural analogue of the registered substance - a trimellitate ester with C8 branched alcohol side chains. A measured BCF of up to 2.7 suggests the potential for bioconcentration in aquatic organisms is low. However, there are some uncertainties in the experimental data mainly due to testing at concentrations above the water solubility of the substance by the use of solubilising agents which are recognised as having the potential to lead to an underestimation of the BCF.
Information for the potential of a substance to bioaccumulate within aquatic organisms may be obtained from toxicokinetic studies with mammals, the available information on the trimellitates indicating that the parent substance is poorly absorbed. (Q)SPR modelling suggests that dermal absorption is expected to be negligible (see Section 7.1.2). Studies in the rat (see Section 7.1.1) indicate that, following oral administration, the substance is partially hydrolysed in the gastro-intestinal tract to the corresponding di-ester and free alcohol and, following further hydrolysis, the mono-ester. Only the alcohol and mono-ester appear to be absorbed with the majority of the administered dose eliminated unchanged in the faeces. Once absorbed, elimination is rapid suggesting that accumulation, particularly in higher trophic organisms, may be low. These considerations suggest that the potential for bioaccumulation is low.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
